Search
AusCann chairman Mal Washer.

Performance shares deliver windfall

The directors of medicinal cannabis companies Creso Pharma and AusCann Group Holdings have reaped windfall gains worth $13 million after the vesting of performance rights and performance shares.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BN30 Index

Index = 100 as of 4 Jan 2016
Source: Morningstar

Total Shareholder Return as at 31/08/18

1 year TSR5 year TSR
56thSportsHero167%-39%
107thAusCann Group Holdings84%187%
553rdNeurotech International-19%0%
633rdPhylogica-33%23%
737 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

09/08/18
$15k Issued
10/05/17
$0 Other
10/05/17
$0 Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

211th↓Neurotech International$67k
212th↓AusCann Group Holdings$54k
214th↓Phylogica$48k
215th↓SportsHero$23k
237 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer